Empowering Research Through Patient Engagement
At iRecruitCeliac, we are dedicated to accelerating the development of treatments for celiac disease and improving the quality of life for patients on a medically necessary gluten-free diet. Powered by the Celiac Disease Foundation, we combine decades of advocacy, research leadership, and patient trust with proprietary digital platforms that deliver unmatched speed and precision in trial recruitment.
Unlike broad recruitment vendors, we work directly with national celiac disease patient organizations across the globe, connecting sponsors and CROs to diagnosis-confirmed patients who meet exact study criteria. The result? Faster enrollment, lower screen-fail rates, and reduced site burden—while ensuring every interaction reflects the cultural and community context of the patients you need to reach.


iQualifyCeliac
Our proprietary, protocol-driven recruitment platform, launched in 2018, accelerates enrollment by matching patients in real time to sponsor-selected sites. With more than 34,000 diagnosis-confirmed patients, geo-targeted referrals, waitlist management, and a secure Study Site Contact Center, iQualifyCeliac streamlines the entire patient journey—from prescreen to enrollment.
iCureCeliac
The world’s largest publicly accessible celiac disease registry, with more than 17,000 participants across 90+ countries contributing real-world patient data to advance research and trial feasibility.
Together, these platforms—and the dedicated team behind them—are redefining what’s possible in global celiac disease research.
pre-screened celiac patients in iQualifyCeliac (U.S. & Canada)
engaged annually via celiac.org & social media, with additional reach by our partners
trial sites in our performance database across the U.S. & Canada
national celiac organizations ensuring global reach and cultural accuracy